1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anti-Infective Drug News FEBRUARY 2016

Anti-Infective Drug News FEBRUARY 2016

  • February 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Zika Virus Opportunities And Threats
Industry Brief - FDA Accepts Teflaro sNDA For Filing
Industry Brief - MGB Biopharma/UoS To Co-Develop Novel MGB Anti-Infectives
Industry Brief - Telephus Secures Australian Patent Covering Therapeutic Abs For Staphylococcus Infections
Industry Brief - Bavarian Nordic Enters Research Collaboration To Develop MRSA Vaccine
Industry Brief - Allergan/AstraZeneca Collaborate To Develop ATM-AVI Antibiotic
Industry Brief - Theravance Launches Vibativ In Canada
Industry Trend Analysis - Reaching Stakeholder Consensus Key To Tackling AMR Threat
Industry Brief - VAXEM Hib Approved In Japan
Industry Brief - FDA Approves Updated Dalvance Dosing
Industry Brief - Cidara's CD101 IV Gains FDA ODD For Candidaemia/Invasive Candidiasis
Industry Brief - SCYNEXIS' Antifungal Receives FDA Fast Track and QIDP Designations
Industry Brief - Aurobindo Gains FDA Voriconazole Approval
Industry Brief - FDA Approves Harvoni For HCV Patients With Advanced Liver Disease
Industry Brief - Health Canada Accepts Sitavig NDA For Review
Industry Brief - Protein Sciences/UNIGEN To Source Flublok From Japan
Industry Brief - FDA Approves Expanded Use Of Daklinza
Industry Brief - Valneva/GSK Enter R&D Collaboration For EB66 Cell Line
Industry Brief - Merck's Zepatier Approved In Canada
Industry Brief - Sanofi Pasteur Targeting Zika Vaccine
Industry Brief - GeoVax To Develop Zika Vaccine
Industry Brief - GSK Seeks US Approval For Expanded Use Of FluLaval Quadrivalent
Industry Brief - NewLink Genetics To Develop New Zika Treatment Options
Industry Brief - UniSA Partners With Biotech Company To Develop Zika Vaccine
Industry Brief - FDA Approves Merck's Fixed-Dose HCV Regimen
Industry Brief - EC Approves Expanded Use Of Daklinza
Industry Trend Analysis - Region To Remain Vulnerable To Zika
Industry Trend Analysis - Zika Outbreak Poses Diagnostic Opportunity
Industry Trend Analysis - Gilead In Strong Position To Counter TAF Lawsuit
Industry Trend Analysis - Gilead To Target Transformational Opportunities
Industry Trend Analysis - Dynamics Within Industry-Academia Partnerships Changing

Table Of Contents

Anti-Infective Drug News FEBRUARY 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.